11/16/18 19:16 | 11/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Phillips Barclay A | NC | O | SVP,CFO | M.d | 97 | 19.46 | 0 | 5 | | 0 | D | | | | | | | | | | | | | | |
11/16/18 19:16 | 11/15/18 | GTHX | G1 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Phillips Barclay A | NC | O | SVP,CFO | S.d | -200 | 39.92 | 0 | -5 | -100 | 0 | D | | | | | | | | | | | | | | |
8/1/17 17:26 | 7/31/17 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 2 | 0.8900 | 0 | 2 | 6 | 39 | D | | | | | | | | | | | | | | |
5/11/17 10:45 | 5/11/17 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 21 | 0.8380 | 4 | 25 | 215 | 37 | D | -90 | -82 | -44 | -37 | -35 | 1 | 1 | 12 | 12 | | | | | |
2/2/17 16:10 | 1/31/17 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 2 | 1.12 | 8 | 2 | 16 | 12 | D | -83 | -72 | -82 | -14 | -7 | -4 | -4 | -2 | 4 | 2 | 15 | -38 | | |
8/2/16 18:17 | 7/31/16 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 2 | 4.29 | 31 | 0 | 4 | 10 | D | 69 | -39 | 46 | 38 | 8 | -5 | -1 | -1 | 6 | 4 | -3 | -78 | -80 | |
2/1/16 17:34 | 1/31/16 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 2 | 4.38 | 33 | 0 | 4 | 10 | D | -10 | -34 | -57 | -30 | -41 | -27 | -17 | -9 | -7 | -4 | -7 | 4 | 44 | -73 |
8/21/15 17:08 | 8/19/15 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | S.m | -374 | 13.06 | 33 | -29 | -76 | 9 | D | 315 | 174 | 30 | 39 | 3 | 2 | -11 | -13 | -12 | -4 | -18 | -36 | -58 | -42 |
8/4/15 16:46 | 7/31/15 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 2 | 2.28 | 33 | 1 | 2 | 38 | D | 352 | 184 | 57 | 51 | 22 | 0 | 1 | 2 | 2 | -5 | -10 | -41 | -58 | -38 |
2/3/15 17:05 | 1/31/15 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 19 | 2.28 | 33 | 8 | 29 | 37 | D | 331 | 42 | 81 | 37 | 30 | 20 | 5 | 1 | 3 | 7 | 18 | 7 | 60 | -36 |
10/6/14 10:17 | 10/3/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 21 | 4.11 | 12 | 5 | 21 | 29 | D | 72 | 27 | 0 | -13 | -9 | -9 | -5 | -1 | 2 | 7 | 34 | 43 | 95 | 73 |
8/4/14 15:12 | 7/31/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 20 | 2.28 | 14 | 9 | 59 | 24 | D | 95 | 59 | -22 | -1 | -15 | -5 | -6 | -5 | 3 | 2 | 14 | 32 | 81 | 184 |
3/25/14 14:09 | 3/25/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P.a | 21 | 4.25 | 33 | 5 | 51 | 15 | D | 215 | 91 | 32 | -12 | -29 | -35 | -24 | -20 | 8 | 10 | 1 | 18 | 4 | 124 |
3/25/14 12:07 | 3/25/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 21 | 4.25 | 33 | 5 | 51 | 15 | D | 215 | 91 | 32 | -12 | -29 | -35 | -24 | -20 | 8 | 10 | 1 | 18 | 4 | 124 |
2/4/14 09:22 | 1/31/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P | 23 | 2.29 | 32 | 10 | New | 10 | D | 251 | 194 | 99 | 71 | 13 | -4 | -17 | -7 | 2 | 10 | 20 | -18 | -17 | 41 |
7/5/13 13:03 | 6/12/13 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP,CFO | P.a | 0 | 0.00 | 3 | 0 | | 0 | D | 16 | 51 | 19 | 3 | 15 | 21 | 16 | 15 | 11 | 9 | 13 | 38 | 122 | 113 |
7/3/13 10:40 | 6/12/13 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | D | | P | 95 | 1.90 | 3 | 50 | 33 | 200 | D | 11 | 53 | 19 | -6 | 15 | 18 | 12 | 14 | 4 | 16 | 19 | 41 | 128 | 123 |
11/12/09 16:01 | 11/9/09 | MITI | Micromet, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP , CF | M.d | 89 | 2.54 | 2 | 35 | | 1 | M | 271 | 45 | 75 | 4 | 6 | 17 | 25 | 9 | -2 | 7 | -1 | 22 | -5 | 6 |
11/12/09 16:01 | 11/9/09 | MITI | Micromet, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | MD | O | SVP , CF | S.d | -214 | 6.10 | 2 | -35 | -96 | 1 | M | 271 | 45 | 75 | 4 | 6 | 17 | 25 | 9 | -2 | 7 | -1 | 22 | -5 | 6 |
6/16/08 16:04 | 6/13/08 | ACOR | Acorda Therapeutics Inc | | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | NY | D | | S | -7,120 | 30.30 | 33 | -235 | -27 | 641 | I | 827 | 67 | 66 | 65 | 42 | 47 | 3 | 0 | -1 | 3 | 8 | -11 | -47 | -14 |
11/6/03 18:01 | 11/4/03 | CNVX | Cancervax Corp | DE | Health | BioPrd | Biological Products, (No Diag | Phillips Barclay A | CA | D | | P | 6 | 12.00 | 0 | 1 | 8 | 7 | M | | | | | | | | | | | | | | |